Project Grant K01HL177266
- The National Heart, Lung, and Blood Institute (NHLBI) has awarded a $751,124 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Kaiser Foundation Hospitals in Pleasanton, CA. The grant supports research to explore the timing and intensity of physical activity, as well as the optimal 24-hour activity compositions, for the prevention of hypertensive disorders of pregnancy, which impact 10-15% of pregnancies and are risk factors for future cardiovascular disease in...
- The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health awarded a $702,964 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to the University of South Carolina (USC). The grant aims to improve implementation of the Exercise is Medicine Greenville (EIMG) program, which assesses patient physical activity levels, provides exercise prescriptions, and refers patients with chronic diseases to community-based physical activity programs....
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $185,760 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Oregon Health & Science University (OHSU). The project, titled "Leveraging Informatics to Optimize Cardiovascular Risk Prediction in Women", aims to support the principal investigator in developing skills in informatics, epidemiology, and preventive cardiology to advance cardiovascular disease (CVD) risk assessment for women. The...
- This $242,250 Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) will fund a feasibility study to assess the use of coronary sinus blood sampling to measure changes in metabolite utilization during submaximal exercise in patients with heart failure. The study aims to implement arteriovenous sampling of the heart and leg to determine regional metabolic changes, with the goal of better understanding exercise limitations in...
- This federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $422,894 to Miami University to investigate the interactive effects of cardiorespiratory fitness and adiposity on the recovery of impaired glucose control and vascular function following a period of reduced physical activity. The 3-year award, effective April 2025, will recruit participants with varying health status to examine glucose control and vascular...
- This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $650,028 to the University of California, Los Angeles (UCLA) to conduct research on the sex-dependent regulation of cardiac cAMP, excitation-contraction coupling, and arrhythmia by phosphodiesterases. The overarching goal is to determine the differential role of PDE4D signaling in contributing to dysfunctional cardiac function and...
- This federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $163,145.00 in funding to the University of Colorado-Denver to conduct research on sex differences in cardiac macrophages and their role in pulmonary hypertension. The 5-year project, which commenced on Sep 1, 2025, seeks to identify how female sex hormones regulate the gene expression and function of right ventricular macrophages, which could explain...
- The University of Chicago was awarded a $275,196 federal Project Grant from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) on September 23, 2025. The grant will support research focused on understanding the impact of adolescent reproductive health factors on the risk of cardiometabolic disease in young adult women. The research will leverage longitudinal data from the Pittsburgh Girls Study to examine associations between pubertal, sexual, and...
- This $192,199 Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) supports the development and piloting of an electronic health record (EHR)-based physical activity intervention to prevent postpartum hypertension progression among women with subclinical blood pressure elevations during pregnancy. The principal investigator, Dr. Natalie Cameron, aims to identify factors influencing postpartum physical activity, develop...
- This federal Project Grant award was provided by the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), to Ursinus College to conduct research on the cardiometabolic adaptations that occur in response to acute and chronic exercise in male and female mice. The primary objectives are to: 1) identify the time course of the metabolic response to acute exercise, 2) determine the adaptations in cardiac substrate utilization and...
The National Heart, Lung, and Blood Institute (NHLBI) has awarded a $136,646 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Duke University to conduct an observational study on sex differences in physical activity (PA) participation during and after cardiac rehabilitation (CR) programs. The study aims to: 1) Identify sex differences in PA participation during and after CR, 2) Determine sex-specific barriers to PA, and 3) Examine key predictors of PA maintenance, with a sub-aim to assess whether the predictors differ by sex. The findings will inform the development of a future R01-level intervention using health coaching and precision strategies to cultivate long-term PA adherence, particularly among women transitioning from CR. The project period runs from Sep 2025 to Aug 2030.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $136.6k | 9/19/25 |